Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01XE01	NITROFURANTOIN	G	Nitrofurantoin - 100mg	100mg	Tablet	972,942 L.L
C01DA02	NITROJECT INJECTION	G	Nitroglycerine - 50mg/10ml	50mg/10ml	Injectable solution	7,018,889 L.L
C01DA02	NITROGLICERINA BIOINDUSTRIA L.I.M.	G	Nitroglycerine - 50mg/50ml	50mg/50ml	Injectable concentrate for solution	1,057,604 L.L
C01CA03	NORADRENALINE HIKMA	G	Noradrenaline bitartrate - 4mg/4ml	4mg/4ml	Injectable solution	1,279,338 L.L
C01CA03	NORADRENALINE NOREPINEPHRINE (tartrate) Aguettant	G	Norepinephrine tartrate - 2mg/ml	2mg/ml	Injectable solution	1,896,162 L.L
C01CA03	NORADRENALINE NOREPINEPHRINE (tartrate) Aguettant	G	Norepinephrine tartrate - 2mg/ml	2mg/ml	Injectable solution	1,896,162 L.L
C01CA03	NORADRENALINE RENAUDIN	G	Norepinephrine tartrate - 8mg/4ml	0.20%	Injectable solution	2,000,981 L.L
S01AE02	NAFLOX	G	Norfloxacin - 3mg/ml	3mg/ml	Drops	370,901 L.L
J01MA06	NOROXIN	B	Norfloxacin - 400mg	400mg	Tablet, film-scored	574,653 L.L
A02BC01	NEOOPRAZOLE	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	407,184 L.L
A04AA01	NAUSETRON	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, scored	1,023,880 L.L
A04AA01	NOZAMET	G	Ondansetron - 4mg	4mg	Film, orodispersible	3,234,181 L.L
A04AA01	NAUSETRON	G	Ondansetron - 4mg/5ml	4mg/5ml	Solution	958,608 L.L
A04AA01	NAUSETRON	G	Ondansetron - 4mg/5ml	4mg/5ml	Solution	802,466 L.L
A04AA01	NOZENTRIX	G	Ondansetron - 8mg	8mg	Tablet, film coated	1,151,865 L.L
A04AA01	NOZAMET	G	Ondansetron - 8mg	8mg	Film, orodispersible	6,075,448 L.L
A03AB06	NOSPAZM	G	Otilonium bromide - 40mg	40mg	Tablet, film coated	282,207 L.L
M03BC51	NORGESIC	B	Paracetamol - 450mg, Orphenadrine (citrate) - 35mg		Tablet	412,560 L.L
N02BE01	NOMAL	G	Paracetamol - 500mg	500mg	Tablet	305,884 L.L
L03AA13	NEULASTIM	BioTech	Pegfilgrastim - 6mg/0.6ml	6mg/0.6ml	Injectable solution	56,925,965 L.L
J07AH08	NIMENRIX	B	Polysaccharide of Neisseria meningitidis (serogroups A, C, Y and W-135) conjugated - 5mcg/0.5ml, Tetanus toxoid carrier protein - 44mcg/0.5ml		Injectable lyophilised powder for solution+diluent	4,483,059 L.L
J02AC04	NOXAFIL	B	Posaconazole - 100mg	100mg	Tablet, gastroresistant	62,027,714 L.L
N02BF02	NERVAX	G	Pregabalin - 150mg	150mg	Capsule	1,955,291 L.L
N02BF02	NEUREXAL	G	Pregabalin - 150mg	150mg	Capsule	754,856 L.L
N02BF02	NEUREXAL	G	Pregabalin - 25mg	25mg	Capsule	321,754 L.L
N02BF02	NERVAX	G	Pregabalin - 75mg	75mg	Capsule	513,348 L.L
N02BF02	NEUREXAL	G	Pregabalin - 75mg	75mg	Capsule	335,577 L.L
N02BF02	NEUREXAL	G	Pregabalin - 75mg	75mg	Capsule	637,365 L.L
C09AA05	NORMOPRIL	G	Ramipril - 10mg	10mg	Tablet	599,354 L.L
C09AA05	NORMOPRIL	G	Ramipril - 2.5mg	2.5mg	Tablet	229,797 L.L